Star Health and Allied Insurance Company has announced multiple analyst and institutional investor meetings scheduled for March 27, 2026 in Mumbai. The insurance company filed this disclosure on March 24, 2026 from Chennai in compliance with regulatory requirements.

Meeting Schedule

The company has scheduled four separate meetings with different institutional investors throughout the day on Friday, March 27, 2026. Each meeting is allocated a one-hour slot to facilitate detailed discussions.

Short Notice Acknowledgment

Due to business exigencies on the part of the investors, the company has intimated the analyst and institutional investor meetings at shorter notice. Star Health has expressed regret for the short notice and commits to ensure timely intimation of future meetings.

Regulatory Compliance

The meeting announcement was made under Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. Company Secretary and Compliance Officer Jayashree Sethuraman signed the disclosure document digitally on March 24, 2026.

Presentation Access

Star Health has provided a presentation link for accessing meeting materials at https://d28c6jni2fmamz.cloudfront.net/ECPQ_3_FY_26_5d8a5d5f4b.pdf . The disclosure will also be made available on the company's official website at www.starhealth.in .

The announcement represents part of the company's ongoing investor relations activities and regulatory disclosure obligations as a listed entity on both BSE and NSE exchanges.

Star Health Insurance has received a positive outlook from Jefferies, with the global brokerage firm initiating a Buy rating and setting a target price of Rs 660 for the health insurance company.

Key Investment Thesis

Jefferies' bullish stance is anchored on the company's potential for substantial operational improvements. The brokerage projects a loss ratio improvement of approximately 200 basis points by FY28, representing a significant enhancement in the company's underwriting profitability.

Growth Drivers and Strategic Initiatives

The expected improvement in loss ratios is attributed to two primary factors: strategic price hikes and enhanced underwriting practices. These measures are designed to optimize the company's risk-reward profile and improve overall profitability metrics.

Beyond the core underwriting improvements, Jefferies identifies several additional growth catalysts:

• Claims Automation: Implementation of automated claims processing systems to enhance efficiency and reduce operational costs
• Hospital Partnerships: Strategic alliances with healthcare providers to expand network coverage and improve service delivery
• Product Innovation Roadmap (PIR): Development of new insurance products to capture emerging market opportunities

Valuation Assessment

The brokerage highlights the attractive valuation proposition, noting that the current trading multiple of 18x FY27E earnings appears to underprice the company's growth potential. Jefferies projects a robust IFRS EPS compound annual growth rate of approximately 21% over the FY26-28 period, suggesting significant upside potential from current levels.

Market Positioning

The positive recommendation reflects confidence in Star Health's ability to execute its strategic initiatives while capitalizing on the growing health insurance market in India. The combination of operational improvements and strategic growth drivers positions the company for sustained performance enhancement in the coming years.